FDA Warning Letter — SimpleRx

Case 715874 — FEI 3039696172

The FDA took a Warning Letter action against SimpleRx on September 9, 2025 (Bellevue, KY). The action was issued by CDER and concerns drugs products.

Action Details

Facility
SimpleRx
Date
September 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Bellevue, KY (United States)